ROCKWELL MEDICAL, INC. Notes Payable
ROCKWELL MEDICAL, INC. (RMTI) had Notes Payable of $0 as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:NotesPayable · last filed 2024-05-14
- 2024-03-31: Notes Payable $0.00.
- 2023-12-31: Notes Payable $244.00K.
- 2023-09-30: Notes Payable $488.00K.
- 2023-06-30: Notes Payable $733.00K.
| Period end | Notes Payable | Notes Payable as first filed |
|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $244.00K 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $488.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $733.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $503.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $1.01M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.51M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $437.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.31M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $0.00 10-K · filed 2022-04-08 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $190.85K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $763.00K 10-K · filed 2021-03-31 | $763.42K 10-K · filed 2020-03-17 |
| 2019-09-30 | $1.15M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.91M 10-Q · filed 2019-08-09 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |